Antiviral nanopharmaceuticals: Engineered surface interactions and virus-selective activity.

Area of Science:

• Nanomedicine
• Toxicology of Nanomaterials
• Infectious Disease Therapeutics

Background:

• The COVID-19 pandemic spurred research into antiviral technologies, including nanotechnology.
• Emerging viruses present challenges due to structural variation and virulence.
• Nanomaterials are vital for vaccines, drugs, and disinfection methods.

Purpose of the Study:

• To review nanotechnology-based virucides and antivirals.
• To discuss design considerations for high-efficacy antiviral nanomaterials.
• To explore future research directions for nanomedicine in infectious disease.

Main Methods:

• Literature review of published studies on nanotechnology-based antivirals.
• Analysis of key design considerations for antiviral nanomaterials.
• Examination of biological activity modes for nanopharmaceuticals.

Main Results:

• Nanomaterials show significant potential in developing broad-spectrum antiviral agents.
• Specific design strategies enhance the efficacy of nanopharmaceuticals against viruses.
• Understanding nanomaterial interactions is key to developing robust antiviral therapies.

Conclusions:

• Nanotechnology is essential for developing next-generation antiviral strategies.
• Further research into nanomedicine is critical for pandemic preparedness.
• Targeted design of nanomaterials can address the threat of SARS-CoV-2 and future viruses.